精神科培训项目与制药行业的接触：一个教育问题，而非严格意义上的伦理问题。
Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one.
作者信息
Mohl Paul C
机构信息
Dept. of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 79390-9070, USA.
出版信息
Acad Psychiatry. 2005 May-Jun;29(2):215-21. doi: 10.1176/appi.ap.29.2.215.
OBJECTIVE
To analyze the educational and ethical issues involved in interactions between departments of psychiatry and the pharmaceutical industry.
METHODS
The author analyzes the history of attitudes toward pharmaceutical companies, various conflicting ethical principles that apply, and areas of confluence and conflict of interest between psychiatric education and the drug industry. These attitudes are applied to a variety of specific types of interactions with representatives of the pharmaceutical industry.
RESULTS
A number of forms of interaction are found to be on balance, ethical, and productive, while others are found to be problematic.
CONCLUSIONS
Careful analysis of both ethical and educational dimensions can produce meaningful and constructive involvement with the pharmaceutical industry, without inevitably corrupting psychiatric educators.
目的
分析精神病学部门与制药行业之间互动中涉及的教育和伦理问题。
方法
作者分析了对制药公司态度的历史、适用的各种相互冲突的伦理原则，以及精神科教育与制药行业之间的利益汇合和冲突领域。这些态度适用于与制药行业代表的各种具体互动类型。
结果
发现一些互动形式总体上是符合伦理且富有成效的，而另一些则存在问题。
结论
对伦理和教育层面进行仔细分析，可以与制药行业进行有意义且建设性的互动，而不一定会腐蚀精神科教育工作者。
Zotero 插件